Category:

Two co-founders of a Taiwan biotechnology company were sentenced Tuesday for plotting to steal trade secrets from Genentech in a $101 million scheme...Racho Jordanov, former CEO of JHL Biotech Inc., and former chief operating officer Rose Lin were sentenced in San Francisco federal court to a year and a day each in federal prison...They pleaded guilty last year to conspiracy to commit trade secret theft and wire fraud...JHL Biotech, now known as Eden Biologics, Inc., is a biopharmaceutical startup based in Taiwan. According to plea agreements, between 2011 and 2019, Jordanov used confidential Genentech information from ex-Genentech workers he hired to speed up and reduce costs for producing generic versions of products made by the South San Francisco-based company...READ MORE

A Johnson & Johnson subsidiary came under attack in court...for attempting to use the bankruptcy process to resolve tens of thousands of claims that its baby powder and other talc-based products caused cancer...The subsidiary, LTL Management, is fighting to remain in bankruptcy, arguing that is the best way to reach an "equitable, efficient, and consensual resolution" of more than 38,000 claims alleging that J&J's talc-based products caused cancers including mesothelioma. J&J maintains that its consumer talc products are safe...J&J used a legal maneuver known as the "Texas two-step," which allows companies to split valuable assets from liabilities through a so-called divisive merger...Lawyers representing cancer patients say that the bankruptcy case is meant to delay and frustrate lawsuits that would otherwise go to a jury trial against J&J directly...READ MORE

Time is running out on a bid by prosecutors and Nevada prison officials to carry out the first execution in the state in almost 16 years, with hearings unfinished in federal court in Las Vegas and decisions pending before the state Supreme Court...One of several drugs that would be used for convicted mass killer Zane Michael Floyd’s lethal injection is due to expire Feb. 28, and because state law calls for two weeks’ notice to schedule an execution...READ MORE

The lion’s share of California cities and counties have signed off on a national settlement with four major pharmaceutical players to resolve allegations that they fueled the opioid crisis, Attorney General Rob Bonta announced...and that deal will award roughly $2.34 billion to state and local governments...The multistate lawsuit alleged that Cardinal, McKesson and AmerisourceBergen -- all major drug distributors -- had not met their legal duty to refuse to ship opioids to pharmacies that submitted suspicious drug orders. Johnson & Johnson misled patients and doctors about the addictive nature of opioids, the state’s alleged...READ MORE

The Sackler family owners of Purdue Pharma LP reached a deal with a group of attorneys general to pay up to $6 billion in cash to resolve widespread litigation alleging that they fueled the U.S. opioid epidemic, bringing the OxyContin maker closer to exiting bankruptcy...The attorneys general for eight states and the District of Columbia, who had blocked a previous settlement that included a $4.3 billion cash payment, announced the deal after weeks of mediation with the Sacklers...The family agreed to pay at least $5.5 billion in cash, which will be used for abating a crisis that has led to nearly 500,000 U.S. opioid overdose deaths over two decades...READ MORE

Following Pfizer and AbbVie, GlaxoSmithKline is the latest drug major to launch a trade secrets case against an ex-staffer. For GSK, the case comes after several other high-profile trade secrets suits that ended in settlements...GSK accused former employee Denise Brooks of trade secrets theft. The company says that on Jan. 13, the defendant “abruptly” resigned from her job as a GSK quality systems lead, a position that gave her “wide-ranging access” to proprietary company data, confidential methods and highly-sensitive trade secrets...READ MORE

Native American tribes in the U.S. have reached settlements over the toll of opioids totaling $590 million with drugmaker Johnson & Johnson and the country’s three largest drug distribution companies, according to a court filing...The filing in U.S. District Court in Cleveland lays out the details of the settlements with Johnson & Johnson and distribution companies AmerisourceBergen, Cardinal Health and McKesson...All federally recognized tribes will be able to participate in the settlements, even if they did not sue over opioids...More than 400 tribes and intertribal organizations representing about 80% of tribal citizens have sued over opioids...READ MORE

Last last year, Moderna lost a legal bid to invalidate two Arbutus Biopharma patents tied to the delivery of its COVID-19 vaccine. At the time, it wasn’t so much a question of whether Arbutus would sue the messenger RNA vaccine giant for infringement, but when. Now...Arbutus and Roivant’s Genevant Sciences on Monday filed a lawsuit against Moderna in the U.S. District Court for the District of Delaware. In their suit, the companies seek damages for infringement on six patents they claim Moderna infringed with the production and sale of its COVID-19 vaccine...The patents relate to nucleic acid-lipid particles and lipid vesicles, plus compositions and methods for their use...READ MORE

State officials and lawyers representing death row inmate Zane Floyd agreed that an execution of the convicted quadruple killer will not happen before a key drug in the state’s lethal injection protocol expires at the end of the month — putting the matter on hold for the foreseeable future...Their statements in federal court on Monday come after the Clark County district attorney’s office did not obtain an execution warrant by Feb. 13, the latest possible day to obtain a warrant and order for a Feb. 28 execution date...READ MORE

Texas federal judge Mark Pittman will conduct a hearing...to consider whether to allow Pfizer to participate in the redaction and release of information about the development of its COVID-19 vaccine, Comirnaty...Earlier this month, Pittman ruled that the FDA would have to turn over 55,000 pages of documentation on the vaccine per month, starting on March 1...Last Friday, Pfizer provided the court a memorandum outlining why it should participate in the process...“Pfizer supports the public disclosure of the vast majority of this information to promote transparency and the public’s confidence in the vaccine,” the company wrote in the filing. “Pfizer seeks to intervene for the limited purpose of ensuring that information that is exempt from disclosure under FOIA is not disclosed inappropriately.”...READ MORE